Chronic Kidney Disease Trial, Recruiting NCT06089057 Sponsor: VA Office of Research and Development Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT06089057
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The participant's kidney specialist and/or regular doctor agrees that the person may take part in the trial
  • People who are considered "pre-frail" based on a walking speed test (taking more than 6 seconds to walk 15 feet), OR who answer "yes" to at least one of the following questions: having difficulty walking about a mile (5–6 blocks) for health or physical reasons; having changed the way they walk half a mile (5–6 blocks) due to health problems; having difficulty climbing one flight of stairs (10 steps) for health or physical reasons; or having changed the way they climb one flight of stairs due to health problems

Who may not be able to join:

  • People who have had a heart attack or unstable chest pain within the past six months
  • People who have had an uncontrolled irregular heart rhythm within the past six months
  • People whose blood pressure has been very high (top number above 180 and/or bottom number above 110) on more than one occasion in the past six months
  • People who have had a stroke or a brief stroke-like episode (sometimes called a "mini-stroke") within the past six months
  • People who have had an abnormal heart stress test within the past year
  • People with a low red blood cell level (hemoglobin of 10 g/dL or less)
  • People with the most severe stage of heart failure (Class IV)
  • People who experience shortness of breath or chest pain while at rest
  • People who rely on a wheelchair to get around
  • People who live permanently in a nursing home or long-term care facility
  • People with a terminal illness or a condition that would qualify them for hospice care
  • People who plan to move away from the Middle Tennessee area within the next year
  • People who have major surgery planned in the next six months
  • People who are blind
  • People who are currently attending physical therapy or a structured exercise program
  • People who are expected to start dialysis or receive a kidney transplant within the next three months
  • People who do not speak English
  • People with severe memory or thinking difficulties

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Devika Nair, MD, Tennessee Valley Healthcare System Nashville Campus, Nashville, TN

Phone: (504) 210-5210

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 July 2026
Est. completion
1 February 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility, as measured by the questionnaire, the Feasibility of Intervention Measure; Feasibility, as measured by a numerical percentage of all participants who consented out of those eligible; Feasibility, as measured by a qualitative description of participants' reasons for declining

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov